t-62
Small moleculeexperimental
The T-62 is a Soviet main battle tank that was first introduced in 1961. As a further development of the T-55 series, the T-62 retained many similar design elements of its predecessor including low profile and thick turret armour. — Wikipedia
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 24, 2007 (NCT00506610)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Adenosine A1 receptorINHIBITOR
ADORA1 inhibitor
- Adenosine A1 receptorMODULATOR
Adenosine A1 receptor modulator
Allosteric modulator
Chemistry & pharmacology
Loading structure…
SMILES
Nc1sc2c(c1C(=O)c1ccc(Cl)cc1)CCCC2- Mol. weight
- 291.8 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaT-62 ↗
- ChEMBLCHEMBL57997 ↗
Also known as
- t-62
- t-62
- t-62
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00809679 | Phase 2 | Dec 1, 2008 | Pfizer |
| NCT00506610 | Phase 2 | Jul 24, 2007 | Pfizer |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 2 | 2 | 1 | 2007 |
1 organizations
Page 1 / 1